BRIEF-Processa Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Priced At-The-Market Under Nasdaq Rules
ReutersJan 28, 2025 1:31 AM
Jan 27 (Reuters) - Processa Pharmaceuticals Inc PCSA.O:
PROCESSA PHARMACEUTICALS ANNOUNCES PRICING OF $5 MILLION PUBLIC OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
PROCESSA PHARMACEUTICALS INC - PURCHASE PRICE PER SHARE $0.615 FOR INSTITUTIONAL INVESTORS, $0.7975 FOR CEO AND BOARD
Source text: ID:nGNX7qXyFC
Further company coverage: PCSA.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing.TradingKey
16 hours ago
.jpg)
Crypto Stocks Ignite ARKK’s Q2 NAV Surge of 46.96%
ARK Innovation ETF (ARKK), managed by Cathie Wood, delivered a stellar performance in Q2 2025, with its net asset value (NAV) soaring by 46.96%, reaffirming Wood’s reputation as one of Wall Street’s most polarizing yet influential fund managers.TradingKey
18 hours ago
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.TradingKey
Wed, Aug 13
.jpg)
